Where does Good T Cells, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Good T Cells, Inc. ranks #19,825 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Good T Cells, Inc. hold?

Good T Cells, Inc. holds 14 US utility patents granted between 2019 and 2024, spanning 7 technology areas.

What is Good T Cells, Inc.'s Innovation Score?

Good T Cells, Inc. has an Innovation Score of 44.2 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Good T Cells, Inc. focus on?

Good T Cells, Inc.'s top technology area is C07K (Peptides) with 14 patents, ranking #671 of 3,615 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Good T Cells, Inc.'s patent grant rate increasing or decreasing?

Good T Cells, Inc.'s recent grant velocity is +1200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Good T Cells, Inc.'s patents?

Good T Cells, Inc.'s patents average 9.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Good T Cells, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Good T Cells, Inc.

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Good ranks #19,825 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#19,825
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.2/100): 9.1
avg claims per patent: +1200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19825 · Foreign Corporation #19,825 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,825/49,997
PHOTO-FINISH Gerber Technology
CPC-NARROW C07K · 7 areas
INNOV-PAR 44.2/100
CLAIMS-PAR 9.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +1200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gerber Technology LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Good’s 44.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (21%) Velocity 20.0 pts (45%) Breadth 9.4 pts (21%) Claim depth 5.5 pts (12%)

Qualcomm Incorporated · highest

85
Good T Cells · this assignee

44
3D Lighting… · lowest

7

What this shows Good's Innovation Score is 44.2/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Good?

Each dot is one of Good’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Good’s own 9.1 claims/patent is at or below the 10.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Good vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Good's grants concentrate

Good T Cells, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2019. By volume, Good sits between Gerber Technology LLC and Green Refrigeration Equipment Engineering Research Center OF Zhuhai Gree Co., Ltd..

Good's three-year grant acceleration

Good T Cells, Inc. shows 11 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Gerber Technology

14
GF Machining Solu…

14
GIST(Gwangju Inst…

14
Gooch AND Housego

14
Goplus

14
GP Acoustics Inte…

14
GP Enterprises

14
Green Refrigerati…

14
Good T Cells ◀

14

What this shows Good holds 14 patents at rank #19,808, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Good

By rank, the assignees closest to #19,808 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Good's primary technology class.

Good's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Good T Cells, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	7.1%
2020	1	7.1%
2021	1	7.1%
2022	4	28.6%
2023	2	14.3%
2024	5	35.7%

Which technologies does Good T Cells, Inc. patent most?

C07K - Peptides 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 14

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Good T Cells, Inc.'s patent record in context - here's where to go next.

Good T Cells, Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #19,825 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Good T Cells, Inc. against Gerber Technology LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.